Moby91d agoneutral
Pfizer Inc. Q1 2026 Earnings Call SummaryMoby summary of Pfizer Inc.'s Q1 2026 earnings call
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
529last 24h
2510last 7d
482● bullish (7d)
257● bearish (7d)
197publishers
Proactive91d agobullish
Pfizer beats Q1 revenue and profit estimates, reaffirms 2026 guidancePfizer Inc (NYSE:PFE, XETRA:PFE) reported first-quarter 2026 revenue and adjusted profit above Wall Street expectations on Tuesday, driven by strong growth in its launched and acquired products, as the drugmaker reaffirmed its full-year financial outlook. The pharmaceutical giant posted...
MT Newswires91d agobearish
Top Midday Stories: PayPal Q2 EPS Guide Undershoots Expectations, Plans 20% Workforce Cut; Palantir Shares Fall Despite Strong Earnings, GuidanceAll three major US stock indexes were up in late-morning trading Tuesday, as oil prices slid despite
MarketBeat92d agoneutral
BioNTech Q1 Earnings Call HighlightsBioNTech (NASDAQ:BNTX) executives used the company’s first-quarter 2026 earnings call to highlight a strategy centered on combination oncology therapies, provide updates on late-stage clinical programs, and outline capital allocation plans that include a $1 billion ADS share repurchase program and m
Zacks92d agoneutral
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Pfizer (PFE) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Quartz92d agobullish
Pfizer Q1 2026 earnings beat estimates on newer drug growthRevenue reached $14.45 billion, up 5% year-over-year, as oncology and other recently launched products offset steep declines in COVID products
Zacks92d agoneutral
Pfizer (PFE) Q1 Earnings and Revenues Top EstimatesPfizer (PFE) delivered earnings and revenue surprises of +5.63% and +4.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Barrons.com92d agobullish
Pfizer Stock Edges Higher as Earnings and Revenue Beat EstimatesPfizer shares rose slightly in premarket trading after the company delivered a first-quarter earnings beat and reaffirmed its full-year outlook. The drugmaker posted adjusted earnings of 75 cents a share, ahead of the 72 cents Wall Street had forecast. Pfizer reaffirmed its full-year guidance, which it initially provided in December.
StockStory92d agoneutral
Pfizer Earnings: What To Look For From PFEGlobal pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors should know.
Benzinga92d agoneutral
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 EarningsPfizer Inc. will release earnings for its third quarter before the opening bell on Tuesday, May 5. Analysts expect the pharmaceutical company to report quarterly earnings of 72 cents per share. That’s down from 92 cents per share in the year-ago period. Benzinga Pro puts the consensus estimate for Pfizer's quarterly revenue at $13.8 billion. Pfizer reported $13.71 billion last year. With the recent buzz around the company, some investors are eyeing potential gains from its dividends. Currently,